SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter & Gamble Hygiene declines as its net profit falls 46% in June quarter

29 Aug 2024 Evaluate

Procter & Gamble Hygiene and Health Care is currently trading at Rs. 16526.95, down by 453.85 points or 2.67 % from its previous closing of Rs. 16980.80 on the BSE.

The scrip opened at Rs. 16805.25 and has touched a high and low of Rs. 16805.25 and Rs. 16342.00 respectively. So far 749 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 19086.20 on 20-Nov-2023 and a 52 week low of Rs. 15306.15 on 14-Mar-2024.

Last one week high and low of the scrip stood at Rs. 17421.00 and Rs. 16342.00 respectively. The current market cap of the company is Rs. 53625.14 crore.

The promoters holding in the company stood at 70.64%, while Institutions and Non-Institutions held 16.72% and 12.65% respectively.

Procter & Gamble Hygiene and Health Care has reported 46.40% fall in net profit at Rs 81.06 crore for quarter ended June 30, 2024 as compared to Rs 151.24 crore for the same quarter in the previous year. However, total income of the company increased by 8.86% at Rs 939.06 crore for June quarter as compared to Rs 862.63 crore for the corresponding quarter previous year.

Procter & Gamble Hygiene and Health Care is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses.

P&G Hygiene Share Price

9931.85 110.60 (1.13%)
15-Apr-2026 10:15 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2162.90
Godrej Consumer Prod 1079.10
Dabur India 430.60
Colgate Palmol. (I) 1930.20
P&G Hygiene 9931.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×